Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
CNS Drugs|April 20, 2004
Central sensitisation and cutaneous allodynia in migraine: implications for treatmentStephen Landy, Kathryn Rice, Bob Lobo
Headache|September 3, 2011
Sumatriptan-naproxen migraine efficacy in allodynic patients: early interventionStephen Landy, Rebecca Hoagland, Nancy A Hoagland
Therapeutic Advances in Neurological Disorders|December 24, 2010
Fixed-dose Sumatriptan/Naproxen Sodium Compared with each Monotherapy Utilizing the Novel Composite Endpoint of Sustained Pain-free/no Adverse EventsStephen Landy, Jonathan White, Shelly E Lener, et al.
Therapeutic Advances in Neurological Disorders|September 3, 2013
Sumatriptan/naproxen sodium combination versus its components administered concomitantly for the acute treatment of migraine: a pragmatic, crossover, open-label outcomes studyStephen Landy, Rebecca Hoagland, Dakota Hoagland, et al.
The Journal of Headache and Pain|August 17, 2018
Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension studyStephen Landy, Sagar Munjal, Elimor Brand-Schieber, et al.
Cephalalgia : an International Journal of Headache|August 16, 2013
Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose studyMary Almas, Stewart J Tepper, Stephen Landy, et al.
Pageof 2